Melissa Adams: Daily

Facing financial headwinds, Mint Inc. pivots into the high-stakes world of AI, unveiling the FLOKI Minibot M1, a personalized companion for Asia.

Flush with cash and nearing major clinical milestones for its neuromuscular disease pipeline, Dyne Therapeutics is set to make its case to investors.

Shipping giant Matson posts strong Q4 results, buoyed by e-commerce and a stable US-China trade deal, and charts a course for growth with a $425M investment.

A Cayman Islands court ruling reveals the crucial role of software experts in resolving a multi-million dollar tech-sector corporate governance dispute.

With strong growth in key sectors but weakness in others, Plexus management faces a pivotal moment at the upcoming Raymond James investor conference.

As MARA preps its Q4 earnings call, investors look beyond Bitcoin to see if its ambitious digital energy and AI infrastructure strategy is paying off.

Ahead of its 2026 blockbuster film, Mattel unveils a massive publishing blitz aimed at transforming Masters of the Universe into a multi-generational saga.

A new report reveals Americans face a $5 trillion annual bill burden, with essential costs consuming an alarming share of income and pushing families to the brink.

With its second Forbes Fintech 50 nod, Zip's autonomous AI agents are saving enterprises billions and transforming procurement into a strategic powerhouse.

A novel implant activating the body's own pathways could offer a safer, more effective alternative to traditional hormone therapies for breast cancer.

DigitalOcean integrates AMD's latest Instinct MI350X GPUs, aiming to democratize high-performance AI inference for startups with its simple, cost-effective cloud.

Ultra Maritime wins a key Navy contract for its ADC MK6 countermeasure, designed to outsmart a new generation of stealthy and lethal enemy torpedoes.

With a new veteran chairman and validated at-home testing, Fellow Health is poised to disrupt the male fertility market. Here's what the move means.

With revenues doubling and a new 'reasoning' AI, Ambient.ai is proving that proactive, automated threat prevention is finally here for enterprise.

Windstar Cruises opens bookings for its ambitious 2027-28 season, tapping into the growing demand for intimate, destination-focused luxury travel.

The green hydrogen firm is acquiring a uranium royalty portfolio, a strategic pivot to power the AI boom and capitalize on nuclear energy's resurgence.

After a turbulent year, Beneficient reports a profitable quarter, resolving major legal woes and regaining Nasdaq compliance, signaling a strategic reset.

Gaxos.ai secures a deal with ByteDance's BytePlus, gaining access to elite AI video models to challenge giants in the booming creator content market.

Profitable and with little debt, this holding company is leveraging a diverse portfolio as it prepares for a major stock market uplist. Here's a closer look.

Acurx Pharmaceuticals preps for pivotal Phase 3 trials for its novel C. diff antibiotic, Ibezapolstat, with global regulatory alignment in place.